A200670 Stock Overview
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 1/6 |
Humedix Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩29,500.00 |
52 Week High | ₩44,500.00 |
52 Week Low | ₩22,500.00 |
Beta | 0 |
1 Month Change | 4.06% |
3 Month Change | -12.59% |
1 Year Change | 26.88% |
3 Year Change | 20.90% |
5 Year Change | 4.80% |
Change since IPO | 3.49% |
Recent News & Updates
Recent updates
Humedix (KOSDAQ:200670) Has A Pretty Healthy Balance Sheet
Mar 09Humedix Co., Ltd.'s (KOSDAQ:200670) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 16Should You Buy Humedix Co., Ltd. (KOSDAQ:200670) For Its Dividend?
Jan 28Are Humedix's (KOSDAQ:200670) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 11What Type Of Returns Would Humedix's(KOSDAQ:200670) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 22Here's Why Humedix (KOSDAQ:200670) Can Manage Its Debt Responsibly
Dec 01Shareholder Returns
A200670 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | 1.0% | 4.3% | 2.4% |
1Y | 26.9% | 28.2% | 12.2% |
Return vs Industry: A200670 underperformed the KR Pharmaceuticals industry which returned 28.8% over the past year.
Return vs Market: A200670 exceeded the KR Market which returned 13% over the past year.
Price Volatility
A200670 volatility | |
---|---|
A200670 Average Weekly Movement | 5.1% |
Pharmaceuticals Industry Average Movement | 4.9% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.9% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A200670 has not had significant price volatility in the past 3 months.
Volatility Over Time: A200670's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | n/a | Jin-hwan Kim | https://humedix.com |
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs.
Humedix Co., Ltd. Fundamentals Summary
A200670 fundamental statistics | |
---|---|
Market cap | ₩306.20b |
Earnings (TTM) | ₩9.06b |
Revenue (TTM) | ₩110.99b |
0.0x
P/E Ratio0.0x
P/S RatioIs A200670 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A200670 income statement (TTM) | |
---|---|
Revenue | ₩110.99b |
Cost of Revenue | ₩66.92b |
Gross Profit | ₩44.07b |
Other Expenses | ₩35.00b |
Earnings | ₩9.06b |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A200670 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yieldn/a
Payout RatioDoes A200670 pay a reliable dividends?
See A200670 dividend history and benchmarksHumedix dividend dates | |
---|---|
Ex Dividend Date | Mar 29 2024 |
Dividend Pay Date | Apr 19 2024 |
Days until Ex dividend | 1 day |
Days until Dividend pay date | 22 days |
Does A200670 pay a reliable dividends?
See A200670 dividend history and benchmarks